Keywords: میلوفیبروز; Hospital dentistry; cancer; gingiva; Abx; Antibiotics; AL; Acute leukemia; ALL; B- and T-lymphoblastic leukemia or lymphoma; AL NOS; Acute leukemia (not otherwise specified); AML; Acute myeloid leukemia; GE; Gingival enlargement; GH; Gingival and periodon
مقالات ISI میلوفیبروز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: میلوفیبروز; Extramedullary hematopoiesis; Mediastinal mass; Myelofibrosis; Pulmonary TB;
Keywords: میلوفیبروز; Dynamic International Prognostic Scoring System (DIPSS); DIPSS plus; Hematopoietic cell transplantation; Myelofibrosis;
Keywords: میلوفیبروز; Leukemia-free survival; Meta-analysis; Molecular markers; Myelofibrosis; Overall survival;
Keywords: میلوفیبروز; Myeloproliferative neoplasms; Myelofibrosis; DIPSS/DIPSS plus; Somatic mutations; Transplant indications; Prognosis;
Keywords: میلوفیبروز; Janus kinase inhibitor; Myelofibrosis; Pulmonary cryptococcosis; Pulmonary nodules; Ruxolitinib; CT; computed tomography; IL; interleukin; JAK; Janus kinase; TNF; tumor necrosis factor;
Keywords: میلوفیبروز; Erythrocytosis; essential thrombocythaemia; JAK inhibitors; myelofibrosis; myeloproliferative; thrombocytosis; polycythaemia vera;
Keywords: میلوفیبروز; Myelofibrosis; Ruxolitinib; Danazol; Cytopenias;
Keywords: میلوفیبروز; Bone marrow histology; Bone marrow reconstitution; Myelofibrosis; Hematopoietic transplant; Reduced-intensity conditioning;
Keywords: میلوفیبروز; Myelofibrosis; Symptoms; Patient-reported outcome; Clinical trials;
Keywords: میلوفیبروز; Myeloproliferative neoplasm; Myelofibrosis; Thrombocytopenia; Quality of life; Symptomatology;
Keywords: میلوفیبروز; Myelofibrosis; Myeloproliferative neoplasia; Splenomegaly; Splenectomy; Allogeneic transplantation;
Keywords: میلوفیبروز; Myelofibrosis; Allogeneic stem cell transplantation; Molecular genetics; Calreticulin; ASXL1;
Keywords: میلوفیبروز; Cancer bone pain; Chiropractic; Myelofibrosis; Pain control;
Keywords: میلوفیبروز; Allogeneic stem cell transplantation; Myelofibrosis;
Keywords: میلوفیبروز; Plateletpheresis; Thrombocytapheresis; Hyperthrombocytosis; Essential thrombocythemia; Myeloproliferative neoplasms; Hydroxyurea; Anagrelide; Interferon; Myelofibrosis; Reactive;
Keywords: میلوفیبروز; AML; acute myeloid leukemia; ASCT; allogeneic stem cell transplant; BETi; bromodomain and extra terminal domain inhibitor; CR; complete remission; DIPSS; Dynamic International Prognostic Scoring System; ET; essential thrombocythemia; FAB; French-American-
Keywords: میلوفیبروز; JAK2V617F mutation; Myeloproliferative neoplasms; JAK2 inhibitors; JAK-STAT signaling; Myelofibrosis; Polycythemia vera; Mutant calreticulin;
Keywords: میلوفیبروز; Leukemia; Lymphoma; Meta-analysis; Myelofibrosis; Splenomegaly; Radiotherapy; Radiation oncology; Palliation; Cancer; Toxicity;
Keywords: میلوفیبروز; feline leukaemia virus; holoprosencephaly; myelofibrosis; pure red cell aplasia;
Keywords: میلوفیبروز; Cardiac tamponade; Pericardial effusion; Extramedullary hematopoiesis; Myeloproliferative neoplasm; Myelofibrosis;
Keywords: میلوفیبروز; Myelofibrosis; Reduced-intensity conditioning regimen;
Keywords: میلوفیبروز; Unrelated donors; Haploidentical donors; Myelofibrosis;
Keywords: میلوفیبروز; Essential thrombocythemia (ET); Transformation; Myelofibrosis; Myelodysplastic syndromes (MDS); Acute myeloid leukemia (AML); Prognostic factors
Keywords: میلوفیبروز; Myelofibrosis; Blast phase; Splenomegaly; Transplantation;
Keywords: میلوفیبروز; Iron overload; Myelofibrosis; Myelodysplastic syndrome; Iron chelation therapy;
Keywords: میلوفیبروز; JAK1/2 inhibitors; Ruxolitinib; Myelofibrosis; Allogeneic transplantation; Survival
Keywords: میلوفیبروز; Myeloproliferative neoplasms; Polycythemia vera; Essential thrombocytosis; Myelofibrosis; JAK2 mutation;
Keywords: میلوفیبروز; Myeloproliferative neoplasm; Polycythemia vera; Essential thrombocythemia; Myelofibrosis; Vascular complications
Keywords: میلوفیبروز; Ruxolitinib; Myelofibrosis; Population study;
Keywords: میلوفیبروز; Myeloproliferative; Myelofibrosis; Primary; Polycythemia; Essential thrombocytosis;
Keywords: میلوفیبروز; Myelofibrosis; Cachexia; Quality of life; Nutritional support; Inflammation;
Keywords: میلوفیبروز; Radioterapia; Mielofibrosis; Terapia dirigidaRadiotherapy; Myelofibrosis; Targeted therapy
Keywords: میلوفیبروز; Anemia; Criteria; Myelofibrosis; Prognosis; Transfusion dependency;
Keywords: میلوفیبروز; Erythrocytosis; Myelofibrosis; Polycythemia; Thrombocythemia; Thrombocytosis;
Keywords: میلوفیبروز; Myeloproliferative neoplasm; Myelofibrosis; Wernicke's encephalopathy; Cardiac disorders
Keywords: میلوفیبروز; Myelofibrosis; Myeloproliferative neoplasm; Stem cell transplant;
Keywords: میلوفیبروز; Bone marrow fibrosis; Fibrosis regression; Myelofibrosis; Allogeneic stem cell transplantation; JAK2 mutation
Keywords: میلوفیبروز; Myelofibrosis; CFU-GM; Spontaneous; Cultures; Methylcellulose;
Keywords: میلوفیبروز; Myelofibrosis; Umbilical cord blood transplantation
Keywords: میلوفیبروز; Essential thrombocythemia; MGUS; Myelofibrosis; Myeloproliferative neoplasm; Polycythemia vera;
Keywords: میلوفیبروز; Myelofibrosis; Allogeneic transplantation; Reduced intensity; Prognosis
Keywords: میلوفیبروز; CHOC; Children's Hospital of Orange County; ITP; Immune thrombocytopenia; IV; Intravenous; IVIG; Intravenous immunoglobulin; MF; Myelofibrosis; TPO; Thrombopoietin; WCMC; Weill Cornell Medical Center;
Keywords: میلوفیبروز; myelofibrosis; allogeneic transplantation; JAK inhibitors; CALR mutation; prognosis; leukemic transformation
Keywords: میلوفیبروز; myelofibrosis; anaemia; myeloproliferative neoplasm; anaemia treatment
Keywords: میلوفیبروز; combination therapy; myelofibrosis; ruxolitinib; panobinostat; decitabine; LDE225; PRM-151
Keywords: میلوفیبروز; Myeloproliferative neoplasms (MPN); Myelofibrosis; Polycythemia vera; Essential thrombocythemia; Hematopoietic stem cell transplantation; Ruxolitinib;
Keywords: میلوفیبروز; JAK inhibitors; Myelofibrosis; Proinflammatory cytokines; Spleen volume; Targeted therapy;
Keywords: میلوفیبروز; Myelofibrosis; Cytokines; Autoimmunity;
SOHO State-of-the-Art Update and Next Questions: MPN
Keywords: میلوفیبروز; Essential thrombocythemia; Midostaurin; Myelofibrosis; Myeloproliferative neoplasms; Pacritinib; Polycythemia vera; Prefibrotic; Ruxolitinib;